KEYWORD INDEX

Click on the first letter of the keyword:
 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Search results for: "O"
Results 1 - 10 of 89 shown below
obesity
Juan R Bustillo, John Lauriello, Katherine Parker, Roger Hammond, Laura Rowland, Michael Bogenschutz and Samuel Keith
Treatment of Weight Gain with Fluoxetine in Olanzapine-Treated Schizophrenic Outpatients
doi:10.1038/sj.npp.1300089
Neuropsychopharmacology 28, 527-529

Abstract | Full text | PDF |
R D Levitan, M Masellis, R W Lam, P Muglia, V S Basile, U Jain, A S Kaplan, S Tharmalingam, S H Kennedy and J L Kennedy
Childhood Inattention and Dysphoria and Adult Obesity Associated with the Dopamine D4 receptor Gene in Overeating Women with Seasonal Affective Disorder
doi:10.1038/sj.npp.1300314
Neuropsychopharmacology 29, 179-186

Abstract | Full text | PDF |
Dan W Haupt, Angela Luber, Justin Maeda, Angela K Melson, Julie A Schweiger and John W Newcomer
Plasma Leptin and Adiposity During Antipsychotic Treatment of Schizophrenia
doi:10.1038/sj.npp.1300563
Neuropsychopharmacology 30, 184-191

Abstract | Full text | PDF |
Marcello Solinas and Steven R Goldberg
Motivational Effects of Cannabinoids and Opioids on Food Reinforcement Depend on Simultaneous Activation of Cannabinoid and Opioid Systems
doi:10.1038/sj.npp.1300720
Neuropsychopharmacology 30, 2035-2045

Abstract | Full text | PDF |
Igor Elman, David Borsook and Scott E Lukas
Food Intake and Reward Mechanisms in Patients with Schizophrenia: Implications for Metabolic Disturbances and Treatment with Second-Generation Antipsychotic Agents
doi:10.1038/sj.npp.1301051
Neuropsychopharmacology aop, -

Murray A Raskind, Brianna L Burke, Norman J Crites, Andre M Tapp and Dennis D Rasmussen
Olanzapine-Induced Weight Gain and Increased Visceral Adiposity is Blocked by Melatonin Replacement Therapy in Rats
doi:10.1038/sj.npp.1301093
Neuropsychopharmacology 32, 284-288

Abstract | Full text | PDF |
object recognition task
Cindy K J Lieben, Arjan Blokland, Ayhan S cedili nodotk, Eric Sung, Petra van Nieuwenhuizen and Rudy Schreiber
The Selective 5-HT6 Receptor Antagonist Ro4368554 Restores Memory Performance in Cholinergic and Serotonergic Models of Memory Deficiency in the Rat
doi:10.1038/sj.npp.1300777
Neuropsychopharmacology 30, 2169-2179

Abstract | Full text | PDF |
Obsessive compulsive disorder
Herbert Meltzer, Bijan Bastani, Karuna Jayathilake and Michael Maes
Fluoxetine, but not Tricyclic Antidepressants, Potentiates the 5-Hydroxytryptophan-Mediated Increase in Plasma Cortisol and Prolactin Secretion in Subjects with Major Depression or with Obsessive Compulsive Disorder
doi:10.1016/S0893-133X(96)00280-1
Neuropsychopharmacology 17, 1-11

Abstract | PDF |
Obsessive compulsive disorder (OCD)
Diana L Martinez and Mark A Geyer
Characterization of the Disruptions of Prepulse Inhibition and Habituation of Startle Induced by alpha-Ethyltryptamine
doi:10.1016/S0893-133X(96)00240-0
Neuropsychopharmacology 16, 246-255

Abstract | PDF |
obsessive–compulsive behaviors
Eric Hollander, Sherie Novotny, Margaret Hanratty, Rona Yaffe, Concetta M DeCaria, Bonnie R Aronowitz and Serge Mosovich
Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders
doi:10.1038/sj.npp.1300021
Neuropsychopharmacology 28, 193-198

Abstract | Full text | PDF |
Obsessive-compulsive disorder
Gerard J Marek, Linda L Carpenter, Christopher J McDougle and Lawrence H Price
Synergistic Action of 5-HT2A Antagonists and Selective Serotonin Reuptake Inhibitors in Neuropsychiatric Disorders
doi:10.1038/sj.npp.1300057
Neuropsychopharmacology 28, 402-412

Abstract | Full text | PDF |
Peter A Tass, Joachim Klosterkötter, Frank Schneider, Doris Lenartz, Anastasios Koulousakis and Volker Sturm
Obsessive-Compulsive Disorder: Development of Demand-Controlled Deep Brain Stimulation with Methods from Stochastic Phase Resetting
doi:10.1038/sj.npp.1300144
Neuropsychopharmacology 28, S27-S34

Abstract | Full text | PDF |
Philip R Szeszko, Shauna MacMillan, Marjorie McMeniman, Elisa Lorch, Rachel Madden, Jennifer Ivey, S Preeya Banerjee, Gregory J Moore and David R Rosenberg
Amygdala Volume Reductions in Pediatric Patients with Obsessive–Compulsive Disorder Treated with Paroxetine: Preliminary Findings
doi:10.1038/sj.npp.1300399
Neuropsychopharmacology 29, 826-832

Abstract | Full text | PDF |
Robert M Bilder, Jan Volavka, Herbert M Lachman and Anthony A Grace
The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes
doi:10.1038/sj.npp.1300542
Neuropsychopharmacology 29, 1943-1961

Abstract | Full text | PDF |
Mostafa El Mansari, Claude Bouchard and Pierre Blier
Alteration of Serotonin Release in the Guinea Pig Orbito-Frontal Cortex by Selective Serotonin Reuptake Inhibitors
doi:10.1016/0893-133X(95)00045-F
Neuropsychopharmacology 13, 117-127

Abstract | PDF |
Allen R Braun, Christopher Randolph, Brigitte Stoetter, Erich Mohr, Christine Cox, Katalin Vladar, Roy Sexton, Richard E Carson, Peter Herscovitch and Thomas N Chase
The Functional Neuroanatomy of Tourette's Syndrome: An FDG-PET Study. II: Relationships between Regional Cerebral Metabolism and Associated Behavioral and Cognitive Features of the Illness
doi:10.1016/0893-133X(95)00052-F
Neuropsychopharmacology 13, 151-168

Abstract | PDF |
David Michelson, Margaret Altemus, Elise Galliven, Lauren Hill, Benjamin D Greenberg and Philip Gold
Naloxone-Induced Pituitary-Adrenal Activation Does Not Differ in Patients with Depression, Obsessive Compulsive Disorder, and Healthy Controls
doi:10.1016/0893-133X(95)00210-5
Neuropsychopharmacology 15, 207-212

PDF |
Gregory L Hanna, Joseph A Himle, George C Curtis, Diane Q Koram, Jeremy Veenstra-Vander Weele, Bennett L Leventhal and Edwin H Cook
Serotonin Transporter and Seasonal Variation in Blood Serotonin in Families with Obsessive-Compulsive Disorder
doi:10.1016/S0893-133X(97)00097-3
Neuropsychopharmacology 18, 102-111

Abstract | PDF |
Stefano Erzegovesi, Livia Martucci, Marta Henin and Laura Bellodi
Low versus Standard Dose mCPP Challenge in Obsessive-Compulsive Patients
doi:10.1016/S0893-133X(00)00178-0
Neuropsychopharmacology 24, 31-36

Abstract | Full text | PDF |
Obsessive-compulsive disorder (OCD)
Daphna Joel and Julia Doljansky
Selective Alleviation of Compulsive Lever-Pressing in Rats by D1, but not D2, Blockade: Possible Implications for the Involvement of D1 Receptors in Obsessive–Compulsive Disorder
doi:10.1038/sj.npp.1300010
Neuropsychopharmacology 28, 77-85

Abstract | Full text | PDF |
Sanjaya Saxena, Arthur L Brody, Karron M Maidment, Jennifer J Dunkin, Mark Colgan, Shervin Alborzian, Michael E Phelps and Lewis R Baxter
Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder
doi:10.1016/S0893-133X(99)00082-2
Neuropsychopharmacology 21, 683-693

Abstract | Full text | PDF |
Occasion setter
Friedbert Weiss, Remi Martin-Fardon, Roberto Ciccocioppo, Tony M Kerr, Diana L Smith and Osnat Ben-Shahar
Enduring Resistance to Extinction of Cocaine-Seeking Behavior Induced by Drug-Related Cues
doi:10.1016/S0893-133X(01)00238-X
Neuropsychopharmacology 25, 361-372

Abstract | Full text | PDF |
Occasion setting
Hans S Crombag, Jeffrey W Grimm and Yavin Shaham
Effect of Dopamine Receptor Antagonists on Renewal of Cocaine Seeking by Reexposure to Drug-associated Contextual Cues
doi:10.1016/S0893-133X(02)00356-1
Neuropsychopharmacology 27, 1006-1015

Abstract | Full text | PDF |
Occasion-setting
Stephan G Anagnostaras, Timothy Schallert and Terry E Robinson
Memory Processes Governing Amphetamine-induced Psychomotor Sensitization
doi:10.1016/S0893-133X(01)00402-X
Neuropsychopharmacology 26, 703-715

Abstract | Full text | PDF |
Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | | Next next
  top go to top

Extra navigation

.
ADVERTISEMENT